Study of Blinking as a Function of Tear Film Quality

Exclusion Criteria

• •Employees of Essilor International, Luxottica, or GrandVision and their subsidiaries
• •Pregnant or breastfeeding women (Article L1121-5)
• •Individuals deprived of liberty by judicial or administrative decision, or hospitalized without consent under Articles L.3212-1 and L.3213-1, who do not fall under Article L.1121-8, and individuals admitted to a health or social care facility for purposes other than research
• •Adults unable or incapable of giving informed consent (Article L1121-8)
• •Participants currently in an exclusion period from another study
• •Participants deemed unfit to participate by the investigator for any reason that may affect subject safety or study integrity All categories of individuals particularly protected under French law are excluded from this research (Articles L1121-5 to L1121-9 of the French Public Health Code).
• •Use of eye drops or ophthalmic solutions within the last 2 hours
• •Wearing contact lenses within the last 48 hours
• •Reported history of severe ocular pathology such as glaucoma, retinitis pigmentosa, diabetic retinopathy, macular involvement, resulting in visual field loss or acuity loss (especially aphakia), except for dry eye (which is not an exclusion criterion)
• •Reported history of eye surgery or trauma to the eye or its adnexa excepted refractive surgery and cataract surgery
• •Reported history of eyelid abnormalities (ptosis)
• •Reported history of neurological deficits, including epilepsy or sensory-motor coordination disorders, vestibular or cerebellar pathology (e.g., balance disorders, nystagmus, Parkinson's disease)
• •Reported history of musculoskeletal disorders preventing maintenance of a fixed head position